| GO:0005575 | cellular_component | 54.43% (166/305) | 1.44 | 0.0 | 0.0 |
| GO:0005200 | structural constituent of cytoskeleton | 6.23% (19/305) | 7.64 | 0.0 | 0.0 |
| GO:0009987 | cellular process | 49.18% (150/305) | 1.42 | 0.0 | 0.0 |
| GO:0008150 | biological_process | 60.0% (183/305) | 1.11 | 0.0 | 0.0 |
| GO:0110165 | cellular anatomical entity | 46.56% (142/305) | 1.4 | 0.0 | 0.0 |
| GO:0007010 | cytoskeleton organization | 9.18% (28/305) | 4.75 | 0.0 | 0.0 |
| GO:0000278 | mitotic cell cycle | 6.23% (19/305) | 6.22 | 0.0 | 0.0 |
| GO:0005874 | microtubule | 7.21% (22/305) | 5.28 | 0.0 | 0.0 |
| GO:0000226 | microtubule cytoskeleton organization | 7.87% (24/305) | 4.92 | 0.0 | 0.0 |
| GO:0099081 | supramolecular polymer | 7.21% (22/305) | 5.15 | 0.0 | 0.0 |
| GO:0099512 | supramolecular fiber | 7.21% (22/305) | 5.15 | 0.0 | 0.0 |
| GO:0099513 | polymeric cytoskeletal fiber | 7.21% (22/305) | 5.15 | 0.0 | 0.0 |
| GO:0007049 | cell cycle | 6.23% (19/305) | 5.74 | 0.0 | 0.0 |
| GO:0003824 | catalytic activity | 44.59% (136/305) | 1.3 | 0.0 | 0.0 |
| GO:0099080 | supramolecular complex | 7.87% (24/305) | 4.54 | 0.0 | 0.0 |
| GO:0007017 | microtubule-based process | 8.2% (25/305) | 4.39 | 0.0 | 0.0 |
| GO:0044283 | small molecule biosynthetic process | 10.16% (31/305) | 3.73 | 0.0 | 0.0 |
| GO:0044249 | cellular biosynthetic process | 17.38% (53/305) | 2.53 | 0.0 | 0.0 |
| GO:0046394 | carboxylic acid biosynthetic process | 8.85% (27/305) | 4.09 | 0.0 | 0.0 |
| GO:0016053 | organic acid biosynthetic process | 8.85% (27/305) | 4.09 | 0.0 | 0.0 |
| GO:1901576 | organic substance biosynthetic process | 17.05% (52/305) | 2.38 | 0.0 | 0.0 |
| GO:0009058 | biosynthetic process | 17.38% (53/305) | 2.33 | 0.0 | 0.0 |
| GO:0003674 | molecular_function | 62.3% (190/305) | 0.82 | 0.0 | 0.0 |
| GO:1901566 | organonitrogen compound biosynthetic process | 10.82% (33/305) | 3.12 | 0.0 | 0.0 |
| GO:0044281 | small molecule metabolic process | 14.1% (43/305) | 2.57 | 0.0 | 0.0 |
| GO:0016740 | transferase activity | 25.25% (77/305) | 1.7 | 0.0 | 0.0 |
| GO:0032561 | guanyl ribonucleotide binding | 6.89% (21/305) | 4.25 | 0.0 | 0.0 |
| GO:0005525 | GTP binding | 6.89% (21/305) | 4.25 | 0.0 | 0.0 |
| GO:0071840 | cellular component organization or biogenesis | 15.41% (47/305) | 2.39 | 0.0 | 0.0 |
| GO:0019001 | guanyl nucleotide binding | 6.89% (21/305) | 4.21 | 0.0 | 0.0 |
| GO:0005737 | cytoplasm | 15.74% (48/305) | 2.29 | 0.0 | 0.0 |
| GO:0051273 | beta-glucan metabolic process | 5.25% (16/305) | 4.93 | 0.0 | 0.0 |
| GO:0051274 | beta-glucan biosynthetic process | 5.25% (16/305) | 4.93 | 0.0 | 0.0 |
| GO:0030243 | cellulose metabolic process | 4.92% (15/305) | 5.17 | 0.0 | 0.0 |
| GO:0030244 | cellulose biosynthetic process | 4.92% (15/305) | 5.17 | 0.0 | 0.0 |
| GO:0009833 | plant-type primary cell wall biogenesis | 4.59% (14/305) | 5.31 | 0.0 | 0.0 |
| GO:0016759 | cellulose synthase activity | 4.59% (14/305) | 5.26 | 0.0 | 0.0 |
| GO:0071704 | organic substance metabolic process | 35.41% (108/305) | 1.21 | 0.0 | 0.0 |
| GO:0008152 | metabolic process | 36.39% (111/305) | 1.18 | 0.0 | 0.0 |
| GO:0005198 | structural molecule activity | 6.89% (21/305) | 3.85 | 0.0 | 0.0 |
| GO:0005802 | trans-Golgi network | 5.57% (17/305) | 4.49 | 0.0 | 0.0 |
| GO:0009832 | plant-type cell wall biogenesis | 4.92% (15/305) | 4.86 | 0.0 | 0.0 |
| GO:0009250 | glucan biosynthetic process | 5.25% (16/305) | 4.57 | 0.0 | 0.0 |
| GO:0098791 | Golgi apparatus subcompartment | 5.57% (17/305) | 4.36 | 0.0 | 0.0 |
| GO:0031984 | organelle subcompartment | 5.57% (17/305) | 4.33 | 0.0 | 0.0 |
| GO:0016760 | cellulose synthase (UDP-forming) activity | 4.26% (13/305) | 5.2 | 0.0 | 0.0 |
| GO:0071669 | plant-type cell wall organization or biogenesis | 4.92% (15/305) | 4.65 | 0.0 | 0.0 |
| GO:0042546 | cell wall biogenesis | 4.92% (15/305) | 4.62 | 0.0 | 0.0 |
| GO:0019752 | carboxylic acid metabolic process | 9.84% (30/305) | 2.76 | 0.0 | 0.0 |
| GO:0043436 | oxoacid metabolic process | 9.84% (30/305) | 2.75 | 0.0 | 0.0 |
| GO:0006082 | organic acid metabolic process | 9.84% (30/305) | 2.75 | 0.0 | 0.0 |
| GO:0003871 | 5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity | 2.3% (7/305) | 8.17 | 0.0 | 0.0 |
| GO:0042085 | 5-methyltetrahydropteroyltri-L-glutamate-dependent methyltransferase activity | 2.3% (7/305) | 8.17 | 0.0 | 0.0 |
| GO:0006520 | amino acid metabolic process | 7.54% (23/305) | 3.29 | 0.0 | 0.0 |
| GO:0000271 | polysaccharide biosynthetic process | 5.25% (16/305) | 4.25 | 0.0 | 0.0 |
| GO:0044042 | glucan metabolic process | 5.25% (16/305) | 4.15 | 0.0 | 0.0 |
| GO:0006996 | organelle organization | 9.18% (28/305) | 2.7 | 0.0 | 0.0 |
| GO:0044237 | cellular metabolic process | 27.87% (85/305) | 1.25 | 0.0 | 0.0 |
| GO:0008172 | S-methyltransferase activity | 2.3% (7/305) | 7.47 | 0.0 | 0.0 |
| GO:0005975 | carbohydrate metabolic process | 9.18% (28/305) | 2.62 | 0.0 | 0.0 |
| GO:0071554 | cell wall organization or biogenesis | 4.92% (15/305) | 4.01 | 0.0 | 0.0 |
| GO:0044238 | primary metabolic process | 31.15% (95/305) | 1.11 | 0.0 | 0.0 |
| GO:0003849 | 3-deoxy-7-phosphoheptulonate synthase activity | 1.97% (6/305) | 8.14 | 0.0 | 0.0 |
| GO:0044085 | cellular component biogenesis | 4.92% (15/305) | 3.99 | 0.0 | 0.0 |
| GO:0016051 | carbohydrate biosynthetic process | 5.25% (16/305) | 3.77 | 0.0 | 0.0 |
| GO:0005976 | polysaccharide metabolic process | 5.25% (16/305) | 3.67 | 0.0 | 0.0 |
| GO:0005829 | cytosol | 8.52% (26/305) | 2.59 | 0.0 | 0.0 |
| GO:0009073 | aromatic amino acid family biosynthetic process | 2.95% (9/305) | 5.41 | 0.0 | 0.0 |
| GO:1901564 | organonitrogen compound metabolic process | 21.31% (65/305) | 1.36 | 0.0 | 0.0 |
| GO:0032950 | regulation of beta-glucan metabolic process | 1.64% (5/305) | 8.31 | 0.0 | 0.0 |
| GO:0032885 | regulation of polysaccharide biosynthetic process | 1.64% (5/305) | 8.31 | 0.0 | 0.0 |
| GO:0010962 | regulation of glucan biosynthetic process | 1.64% (5/305) | 8.31 | 0.0 | 0.0 |
| GO:0032951 | regulation of beta-glucan biosynthetic process | 1.64% (5/305) | 8.31 | 0.0 | 0.0 |
| GO:0010330 | cellulose synthase complex | 1.64% (5/305) | 8.31 | 0.0 | 0.0 |
| GO:2001006 | regulation of cellulose biosynthetic process | 1.64% (5/305) | 8.31 | 0.0 | 0.0 |
| GO:0051211 | anisotropic cell growth | 1.64% (5/305) | 8.31 | 0.0 | 0.0 |
| GO:1903047 | mitotic cell cycle process | 4.92% (15/305) | 3.58 | 0.0 | 0.0 |
| GO:1901135 | carbohydrate derivative metabolic process | 6.56% (20/305) | 2.9 | 0.0 | 0.0 |
| GO:0009071 | serine family amino acid catabolic process | 1.97% (6/305) | 7.12 | 0.0 | 0.0 |
| GO:0009072 | aromatic amino acid metabolic process | 3.28% (10/305) | 4.67 | 0.0 | 0.0 |
| GO:0035251 | UDP-glucosyltransferase activity | 4.59% (14/305) | 3.62 | 0.0 | 0.0 |
| GO:0046527 | glucosyltransferase activity | 4.92% (15/305) | 3.44 | 0.0 | 0.0 |
| GO:0070905 | serine binding | 1.64% (5/305) | 7.87 | 0.0 | 0.0 |
| GO:0019264 | glycine biosynthetic process from serine | 1.64% (5/305) | 7.87 | 0.0 | 0.0 |
| GO:0004372 | glycine hydroxymethyltransferase activity | 1.64% (5/305) | 7.87 | 0.0 | 0.0 |
| GO:0016043 | cellular component organization | 10.49% (32/305) | 1.99 | 0.0 | 0.0 |
| GO:0006565 | L-serine catabolic process | 1.64% (5/305) | 7.62 | 0.0 | 0.0 |
| GO:0043255 | regulation of carbohydrate biosynthetic process | 1.64% (5/305) | 7.54 | 0.0 | 0.0 |
| GO:0006790 | sulfur compound metabolic process | 4.26% (13/305) | 3.62 | 0.0 | 0.0 |
| GO:0008652 | amino acid biosynthetic process | 3.93% (12/305) | 3.82 | 0.0 | 0.0 |
| GO:0016741 | transferase activity, transferring one-carbon groups | 5.25% (16/305) | 3.11 | 0.0 | 0.0 |
| GO:0032881 | regulation of polysaccharide metabolic process | 1.64% (5/305) | 7.43 | 0.0 | 0.0 |
| GO:0044272 | sulfur compound biosynthetic process | 3.28% (10/305) | 4.32 | 0.0 | 0.0 |
| GO:0046655 | folic acid metabolic process | 1.64% (5/305) | 7.41 | 0.0 | 0.0 |
| GO:0022402 | cell cycle process | 5.57% (17/305) | 2.91 | 0.0 | 0.0 |
| GO:0016049 | cell growth | 1.97% (6/305) | 6.27 | 0.0 | 0.0 |
| GO:0043167 | ion binding | 22.62% (69/305) | 1.14 | 0.0 | 0.0 |
| GO:0006544 | glycine metabolic process | 1.97% (6/305) | 6.15 | 0.0 | 0.0 |
| GO:0050897 | cobalt ion binding | 1.64% (5/305) | 7.06 | 0.0 | 0.0 |
| GO:0040007 | growth | 1.97% (6/305) | 6.09 | 0.0 | 0.0 |
| GO:0016597 | amino acid binding | 1.64% (5/305) | 7.02 | 0.0 | 0.0 |
| GO:0019205 | nucleobase-containing compound kinase activity | 2.3% (7/305) | 5.32 | 0.0 | 0.0 |
| GO:0003979 | UDP-glucose 6-dehydrogenase activity | 1.31% (4/305) | 8.19 | 0.0 | 0.0 |
| GO:0043648 | dicarboxylic acid metabolic process | 2.95% (9/305) | 4.31 | 0.0 | 0.0 |
| GO:0006807 | nitrogen compound metabolic process | 24.59% (75/305) | 1.03 | 0.0 | 0.0 |
| GO:0035999 | tetrahydrofolate interconversion | 1.64% (5/305) | 6.65 | 0.0 | 0.0 |
| GO:0006109 | regulation of carbohydrate metabolic process | 1.64% (5/305) | 6.54 | 0.0 | 0.0 |
| GO:0005886 | plasma membrane | 8.2% (25/305) | 2.06 | 0.0 | 0.0 |
| GO:0006098 | pentose-phosphate shunt | 1.64% (5/305) | 6.51 | 0.0 | 0.0 |
| GO:0009059 | macromolecule biosynthetic process | 6.56% (20/305) | 2.38 | 0.0 | 0.0 |
| GO:0003878 | ATP citrate synthase activity | 1.31% (4/305) | 7.66 | 0.0 | 0.0 |
| GO:0006022 | aminoglycan metabolic process | 1.97% (6/305) | 5.49 | 0.0 | 0.0 |
| GO:0008104 | protein localization | 5.57% (17/305) | 2.58 | 0.0 | 0.0 |
| GO:0070727 | cellular macromolecule localization | 5.57% (17/305) | 2.58 | 0.0 | 0.0 |
| GO:0033036 | macromolecule localization | 5.57% (17/305) | 2.57 | 0.0 | 0.0 |
| GO:0051641 | cellular localization | 6.56% (20/305) | 2.31 | 0.0 | 0.0 |
| GO:1901605 | alpha-amino acid metabolic process | 3.93% (12/305) | 3.26 | 0.0 | 0.0 |
| GO:0016742 | hydroxymethyl-, formyl- and related transferase activity | 1.64% (5/305) | 6.22 | 0.0 | 0.0 |
| GO:0006545 | glycine biosynthetic process | 1.64% (5/305) | 6.22 | 0.0 | 0.0 |
| GO:0008017 | microtubule binding | 3.61% (11/305) | 3.44 | 0.0 | 0.0 |
| GO:1901607 | alpha-amino acid biosynthetic process | 3.28% (10/305) | 3.67 | 0.0 | 0.0 |
| GO:0036094 | small molecule binding | 17.38% (53/305) | 1.21 | 0.0 | 0.0 |
| GO:0072521 | purine-containing compound metabolic process | 4.26% (13/305) | 3.03 | 0.0 | 0.0 |
| GO:0003924 | GTPase activity | 3.61% (11/305) | 3.38 | 0.0 | 0.0 |
| GO:0006730 | one-carbon metabolic process | 1.64% (5/305) | 6.06 | 0.0 | 0.0 |
| GO:0015631 | tubulin binding | 3.61% (11/305) | 3.34 | 0.0 | 0.0 |
| GO:0046653 | tetrahydrofolate metabolic process | 1.64% (5/305) | 6.02 | 0.0 | 0.0 |
| GO:1901363 | heterocyclic compound binding | 17.05% (52/305) | 1.19 | 0.0 | 0.0 |
| GO:0046500 | S-adenosylmethionine metabolic process | 1.31% (4/305) | 7.11 | 0.0 | 0.0 |
| GO:0009086 | methionine biosynthetic process | 1.64% (5/305) | 5.94 | 0.0 | 0.0 |
| GO:0016758 | hexosyltransferase activity | 4.92% (15/305) | 2.66 | 0.0 | 0.0 |
| GO:0004013 | adenosylhomocysteinase activity | 0.98% (3/305) | 8.94 | 0.0 | 0.0 |
| GO:0033353 | S-adenosylmethionine cycle | 0.98% (3/305) | 8.94 | 0.0 | 0.0 |
| GO:0031209 | SCAR complex | 1.31% (4/305) | 7.06 | 0.0 | 0.0 |
| GO:0008194 | UDP-glycosyltransferase activity | 4.59% (14/305) | 2.77 | 0.0 | 0.0 |
| GO:0006023 | aminoglycan biosynthetic process | 1.31% (4/305) | 7.04 | 0.0 | 0.0 |
| GO:0006024 | glycosaminoglycan biosynthetic process | 1.31% (4/305) | 7.04 | 0.0 | 0.0 |
| GO:0006555 | methionine metabolic process | 1.64% (5/305) | 5.83 | 0.0 | 0.0 |
| GO:0055086 | nucleobase-containing small molecule metabolic process | 4.59% (14/305) | 2.75 | 0.0 | 0.0 |
| GO:0006740 | NADPH regeneration | 1.64% (5/305) | 5.81 | 0.0 | 0.0 |
| GO:0016744 | transketolase or transaldolase activity | 1.64% (5/305) | 5.71 | 0.0 | 0.0 |
| GO:0008092 | cytoskeletal protein binding | 4.26% (13/305) | 2.83 | 0.0 | 0.0 |
| GO:0005794 | Golgi apparatus | 3.61% (11/305) | 3.1 | 0.0 | 1e-06 |
| GO:0043168 | anion binding | 16.39% (50/305) | 1.15 | 0.0 | 1e-06 |
| GO:0032991 | protein-containing complex | 12.13% (37/305) | 1.39 | 0.0 | 1e-06 |
| GO:0046508 | hydrolase activity, acting on carbon-sulfur bonds | 0.98% (3/305) | 8.28 | 0.0 | 1e-06 |
| GO:0019438 | aromatic compound biosynthetic process | 5.57% (17/305) | 2.27 | 0.0 | 1e-06 |
| GO:1901565 | organonitrogen compound catabolic process | 4.59% (14/305) | 2.58 | 0.0 | 1e-06 |
| GO:0030866 | cortical actin cytoskeleton organization | 0.98% (3/305) | 8.14 | 0.0 | 1e-06 |
| GO:0030031 | cell projection assembly | 0.98% (3/305) | 8.14 | 0.0 | 1e-06 |
| GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 2.3% (7/305) | 4.16 | 0.0 | 1e-06 |
| GO:1901606 | alpha-amino acid catabolic process | 2.3% (7/305) | 4.15 | 0.0 | 1e-06 |
| GO:0006725 | cellular aromatic compound metabolic process | 12.79% (39/305) | 1.31 | 0.0 | 1e-06 |
| GO:1901137 | carbohydrate derivative biosynthetic process | 3.61% (11/305) | 2.98 | 0.0 | 1e-06 |
| GO:0046417 | chorismate metabolic process | 1.31% (4/305) | 6.3 | 0.0 | 2e-06 |
| GO:0000902 | cell morphogenesis | 1.64% (5/305) | 5.28 | 0.0 | 2e-06 |
| GO:0009063 | amino acid catabolic process | 2.3% (7/305) | 4.05 | 0.0 | 2e-06 |
| GO:0006563 | L-serine metabolic process | 1.64% (5/305) | 5.22 | 0.0 | 2e-06 |
| GO:0051287 | NAD binding | 2.3% (7/305) | 4.03 | 0.0 | 2e-06 |
| GO:0006739 | NADP metabolic process | 1.64% (5/305) | 5.17 | 0.0 | 2e-06 |
| GO:0030203 | glycosaminoglycan metabolic process | 1.31% (4/305) | 6.16 | 0.0 | 2e-06 |
| GO:0006760 | folic acid-containing compound metabolic process | 1.64% (5/305) | 5.15 | 0.0 | 2e-06 |
| GO:0030030 | cell projection organization | 0.98% (3/305) | 7.72 | 0.0 | 3e-06 |
| GO:0051668 | localization within membrane | 2.62% (8/305) | 3.61 | 0.0 | 3e-06 |
| GO:0005488 | binding | 35.08% (107/305) | 0.64 | 0.0 | 3e-06 |
| GO:0042558 | pteridine-containing compound metabolic process | 1.64% (5/305) | 5.08 | 0.0 | 3e-06 |
| GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 2.95% (9/305) | 3.3 | 0.0 | 3e-06 |
| GO:0009069 | serine family amino acid metabolic process | 1.97% (6/305) | 4.42 | 0.0 | 3e-06 |
| GO:0051156 | glucose 6-phosphate metabolic process | 1.64% (5/305) | 5.07 | 1e-06 | 3e-06 |
| GO:0016020 | membrane | 13.77% (42/305) | 1.19 | 1e-06 | 3e-06 |
| GO:0017076 | purine nucleotide binding | 15.08% (46/305) | 1.12 | 1e-06 | 4e-06 |
| GO:0072657 | protein localization to membrane | 2.3% (7/305) | 3.86 | 1e-06 | 4e-06 |
| GO:0004001 | adenosine kinase activity | 0.98% (3/305) | 7.4 | 1e-06 | 5e-06 |
| GO:0009653 | anatomical structure morphogenesis | 1.64% (5/305) | 4.9 | 1e-06 | 5e-06 |
| GO:0043174 | nucleoside salvage | 0.98% (3/305) | 7.36 | 1e-06 | 5e-06 |
| GO:0006166 | purine ribonucleoside salvage | 0.98% (3/305) | 7.36 | 1e-06 | 5e-06 |
| GO:1901265 | nucleoside phosphate binding | 15.41% (47/305) | 1.08 | 1e-06 | 5e-06 |
| GO:0000166 | nucleotide binding | 15.41% (47/305) | 1.08 | 1e-06 | 5e-06 |
| GO:0016174 | NAD(P)H oxidase H2O2-forming activity | 1.31% (4/305) | 5.77 | 1e-06 | 6e-06 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 12.46% (38/305) | 1.24 | 1e-06 | 6e-06 |
| GO:0046912 | acyltransferase activity, acyl groups converted into alkyl on transfer | 1.31% (4/305) | 5.76 | 1e-06 | 6e-06 |
| GO:0000097 | sulfur amino acid biosynthetic process | 1.64% (5/305) | 4.83 | 1e-06 | 6e-06 |
| GO:1901360 | organic cyclic compound metabolic process | 12.46% (38/305) | 1.23 | 1e-06 | 6e-06 |
| GO:0032051 | clathrin light chain binding | 0.98% (3/305) | 7.24 | 1e-06 | 6e-06 |
| GO:0071439 | clathrin complex | 0.98% (3/305) | 7.24 | 1e-06 | 6e-06 |
| GO:0030865 | cortical cytoskeleton organization | 1.31% (4/305) | 5.7 | 1e-06 | 7e-06 |
| GO:0031406 | carboxylic acid binding | 1.64% (5/305) | 4.77 | 1e-06 | 7e-06 |
| GO:0043177 | organic acid binding | 1.64% (5/305) | 4.77 | 1e-06 | 7e-06 |
| GO:0000096 | sulfur amino acid metabolic process | 1.64% (5/305) | 4.7 | 2e-06 | 9e-06 |
| GO:0008168 | methyltransferase activity | 3.61% (11/305) | 2.63 | 2e-06 | 1.3e-05 |
| GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 1.31% (4/305) | 5.46 | 3e-06 | 1.3e-05 |
| GO:0046128 | purine ribonucleoside metabolic process | 0.98% (3/305) | 6.83 | 3e-06 | 1.4e-05 |
| GO:0009163 | nucleoside biosynthetic process | 0.98% (3/305) | 6.83 | 3e-06 | 1.4e-05 |
| GO:0042451 | purine nucleoside biosynthetic process | 0.98% (3/305) | 6.83 | 3e-06 | 1.4e-05 |
| GO:0034404 | nucleobase-containing small molecule biosynthetic process | 0.98% (3/305) | 6.83 | 3e-06 | 1.4e-05 |
| GO:0042455 | ribonucleoside biosynthetic process | 0.98% (3/305) | 6.83 | 3e-06 | 1.4e-05 |
| GO:0046129 | purine ribonucleoside biosynthetic process | 0.98% (3/305) | 6.83 | 3e-06 | 1.4e-05 |
| GO:1901362 | organic cyclic compound biosynthetic process | 5.25% (16/305) | 2.03 | 3e-06 | 1.4e-05 |
| GO:0009119 | ribonucleoside metabolic process | 0.98% (3/305) | 6.75 | 3e-06 | 1.6e-05 |
| GO:0006163 | purine nucleotide metabolic process | 3.28% (10/305) | 2.74 | 4e-06 | 1.7e-05 |
| GO:0008270 | zinc ion binding | 4.92% (15/305) | 2.09 | 4e-06 | 1.8e-05 |
| GO:0072522 | purine-containing compound biosynthetic process | 2.3% (7/305) | 3.47 | 4e-06 | 2.1e-05 |
| GO:0004017 | adenylate kinase activity | 0.98% (3/305) | 6.6 | 5e-06 | 2.2e-05 |
| GO:0004802 | transketolase activity | 0.98% (3/305) | 6.57 | 5e-06 | 2.3e-05 |
| GO:0019206 | nucleoside kinase activity | 0.98% (3/305) | 6.57 | 5e-06 | 2.3e-05 |
| GO:0009070 | serine family amino acid biosynthetic process | 1.64% (5/305) | 4.4 | 5e-06 | 2.3e-05 |
| GO:0009067 | aspartate family amino acid biosynthetic process | 1.64% (5/305) | 4.39 | 5e-06 | 2.4e-05 |
| GO:0016757 | glycosyltransferase activity | 4.92% (15/305) | 2.05 | 5e-06 | 2.5e-05 |
| GO:0006575 | cellular modified amino acid metabolic process | 1.64% (5/305) | 4.27 | 7e-06 | 3.5e-05 |
| GO:1901659 | glycosyl compound biosynthetic process | 0.98% (3/305) | 6.3 | 9e-06 | 4e-05 |
| GO:0006085 | acetyl-CoA biosynthetic process | 1.31% (4/305) | 4.99 | 9e-06 | 4.2e-05 |
| GO:0055038 | recycling endosome membrane | 0.98% (3/305) | 6.26 | 9e-06 | 4.2e-05 |
| GO:0005643 | nuclear pore | 1.64% (5/305) | 4.21 | 9e-06 | 4.3e-05 |
| GO:0009423 | chorismate biosynthetic process | 0.98% (3/305) | 6.24 | 1e-05 | 4.4e-05 |
| GO:0071616 | acyl-CoA biosynthetic process | 1.31% (4/305) | 4.94 | 1e-05 | 4.7e-05 |
| GO:0035384 | thioester biosynthetic process | 1.31% (4/305) | 4.94 | 1e-05 | 4.7e-05 |
| GO:0016477 | cell migration | 0.98% (3/305) | 6.17 | 1.1e-05 | 5e-05 |
| GO:0043231 | intracellular membrane-bounded organelle | 14.1% (43/305) | 1.01 | 1.1e-05 | 5e-05 |
| GO:0006767 | water-soluble vitamin metabolic process | 1.64% (5/305) | 4.15 | 1.1e-05 | 5.1e-05 |
| GO:0043227 | membrane-bounded organelle | 14.1% (43/305) | 1.0 | 1.3e-05 | 5.9e-05 |
| GO:0048870 | cell motility | 0.98% (3/305) | 6.07 | 1.4e-05 | 6.1e-05 |
| GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor | 0.98% (3/305) | 6.05 | 1.4e-05 | 6.3e-05 |
| GO:0032588 | trans-Golgi network membrane | 0.98% (3/305) | 6.02 | 1.5e-05 | 6.7e-05 |
| GO:0009117 | nucleotide metabolic process | 3.28% (10/305) | 2.49 | 1.6e-05 | 6.8e-05 |
| GO:0048040 | UDP-glucuronate decarboxylase activity | 0.98% (3/305) | 6.01 | 1.6e-05 | 6.9e-05 |
| GO:0042732 | D-xylose metabolic process | 0.98% (3/305) | 6.01 | 1.6e-05 | 6.9e-05 |
| GO:0009066 | aspartate family amino acid metabolic process | 1.64% (5/305) | 4.03 | 1.6e-05 | 7.1e-05 |
| GO:0003866 | 3-phosphoshikimate 1-carboxyvinyltransferase activity | 0.66% (2/305) | 8.36 | 1.7e-05 | 7.3e-05 |
| GO:0009506 | plasmodesma | 1.97% (6/305) | 3.52 | 1.7e-05 | 7.3e-05 |
| GO:0006753 | nucleoside phosphate metabolic process | 3.28% (10/305) | 2.48 | 1.7e-05 | 7.3e-05 |
| GO:0005911 | cell-cell junction | 1.97% (6/305) | 3.52 | 1.8e-05 | 7.5e-05 |
| GO:0070161 | anchoring junction | 1.97% (6/305) | 3.51 | 1.8e-05 | 7.7e-05 |
| GO:0030054 | cell junction | 1.97% (6/305) | 3.49 | 1.9e-05 | 8e-05 |
| GO:0046395 | carboxylic acid catabolic process | 2.3% (7/305) | 3.1 | 2.2e-05 | 9.1e-05 |
| GO:0016054 | organic acid catabolic process | 2.3% (7/305) | 3.1 | 2.2e-05 | 9.1e-05 |
| GO:0042278 | purine nucleoside metabolic process | 0.98% (3/305) | 5.83 | 2.3e-05 | 9.4e-05 |
| GO:0006766 | vitamin metabolic process | 1.64% (5/305) | 3.93 | 2.3e-05 | 9.5e-05 |
| GO:0016413 | O-acetyltransferase activity | 1.64% (5/305) | 3.93 | 2.3e-05 | 9.6e-05 |
| GO:0006084 | acetyl-CoA metabolic process | 1.31% (4/305) | 4.58 | 2.7e-05 | 0.000112 |
| GO:0006091 | generation of precursor metabolites and energy | 2.62% (8/305) | 2.78 | 2.8e-05 | 0.000115 |
| GO:0046872 | metal ion binding | 7.87% (24/305) | 1.36 | 2.9e-05 | 0.000119 |
| GO:0006897 | endocytosis | 1.64% (5/305) | 3.77 | 4e-05 | 0.00016 |
| GO:0004801 | transaldolase activity | 0.66% (2/305) | 7.7 | 4.4e-05 | 0.000176 |
| GO:0043169 | cation binding | 7.87% (24/305) | 1.33 | 4.4e-05 | 0.000177 |
| GO:0017111 | ribonucleoside triphosphate phosphatase activity | 4.26% (13/305) | 1.95 | 4.4e-05 | 0.000177 |
| GO:0034033 | purine nucleoside bisphosphate biosynthetic process | 1.31% (4/305) | 4.38 | 4.7e-05 | 0.000187 |
| GO:0034030 | ribonucleoside bisphosphate biosynthetic process | 1.31% (4/305) | 4.38 | 4.7e-05 | 0.000187 |
| GO:0033866 | nucleoside bisphosphate biosynthetic process | 1.31% (4/305) | 4.38 | 4.7e-05 | 0.000187 |
| GO:0015031 | protein transport | 3.28% (10/305) | 2.28 | 5.4e-05 | 0.000213 |
| GO:0016192 | vesicle-mediated transport | 3.61% (11/305) | 2.14 | 5.5e-05 | 0.000214 |
| GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H | 0.66% (2/305) | 7.42 | 6.5e-05 | 0.000252 |
| GO:0043101 | purine-containing compound salvage | 0.98% (3/305) | 5.29 | 6.9e-05 | 0.000268 |
| GO:0010499 | proteasomal ubiquitin-independent protein catabolic process | 0.66% (2/305) | 7.36 | 7e-05 | 0.000273 |
| GO:0140033 | acetylation-dependent protein binding | 0.66% (2/305) | 7.3 | 7.6e-05 | 0.000294 |
| GO:0070577 | lysine-acetylated histone binding | 0.66% (2/305) | 7.3 | 7.6e-05 | 0.000294 |
| GO:0070279 | vitamin B6 binding | 1.64% (5/305) | 3.55 | 7.9e-05 | 0.000301 |
| GO:0030170 | pyridoxal phosphate binding | 1.64% (5/305) | 3.55 | 7.9e-05 | 0.000301 |
| GO:0006633 | fatty acid biosynthetic process | 1.64% (5/305) | 3.55 | 8e-05 | 0.000303 |
| GO:0006144 | purine nucleobase metabolic process | 0.98% (3/305) | 5.22 | 8e-05 | 0.000304 |
| GO:0070403 | NAD+ binding | 0.98% (3/305) | 5.22 | 8e-05 | 0.000304 |
| GO:0006099 | tricarboxylic acid cycle | 1.31% (4/305) | 4.18 | 8.1e-05 | 0.000306 |
| GO:0009116 | nucleoside metabolic process | 0.98% (3/305) | 5.19 | 8.5e-05 | 0.000318 |
| GO:0043226 | organelle | 14.75% (45/305) | 0.86 | 8.6e-05 | 0.000318 |
| GO:0043229 | intracellular organelle | 14.75% (45/305) | 0.86 | 8.5e-05 | 0.000318 |
| GO:0016462 | pyrophosphatase activity | 4.26% (13/305) | 1.85 | 8.7e-05 | 0.000321 |
| GO:0031109 | microtubule polymerization or depolymerization | 0.98% (3/305) | 5.17 | 8.8e-05 | 0.000324 |
| GO:0050145 | nucleoside monophosphate kinase activity | 0.98% (3/305) | 5.12 | 9.8e-05 | 0.000359 |
| GO:0032553 | ribonucleotide binding | 12.79% (39/305) | 0.92 | 0.000101 | 0.000371 |
| GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.26% (13/305) | 1.83 | 0.000103 | 0.000374 |
| GO:0046914 | transition metal ion binding | 5.9% (18/305) | 1.49 | 0.000105 | 0.000383 |
| GO:0046496 | nicotinamide nucleotide metabolic process | 1.97% (6/305) | 3.03 | 0.00011 | 0.000397 |
| GO:0016817 | hydrolase activity, acting on acid anhydrides | 4.26% (13/305) | 1.81 | 0.000113 | 0.000404 |
| GO:0019362 | pyridine nucleotide metabolic process | 1.97% (6/305) | 3.03 | 0.000112 | 0.000405 |
| GO:0097367 | carbohydrate derivative binding | 12.79% (39/305) | 0.91 | 0.000119 | 0.000424 |
| GO:0051179 | localization | 8.85% (27/305) | 1.14 | 0.000132 | 0.00047 |
| GO:0098657 | import into cell | 1.64% (5/305) | 3.39 | 0.000135 | 0.000478 |
| GO:0072524 | pyridine-containing compound metabolic process | 1.97% (6/305) | 2.96 | 0.000145 | 0.000512 |
| GO:0043603 | amide metabolic process | 2.95% (9/305) | 2.23 | 0.000162 | 0.000572 |
| GO:0044282 | small molecule catabolic process | 2.3% (7/305) | 2.63 | 0.000165 | 0.000575 |
| GO:0006637 | acyl-CoA metabolic process | 1.31% (4/305) | 3.91 | 0.000164 | 0.000575 |
| GO:0035383 | thioester metabolic process | 1.31% (4/305) | 3.91 | 0.000164 | 0.000575 |
| GO:1901657 | glycosyl compound metabolic process | 0.98% (3/305) | 4.86 | 0.000167 | 0.000582 |
| GO:0019321 | pentose metabolic process | 0.98% (3/305) | 4.85 | 0.00017 | 0.000589 |
| GO:0016787 | hydrolase activity | 10.82% (33/305) | 0.98 | 0.000178 | 0.000614 |
| GO:0032555 | purine ribonucleotide binding | 12.46% (38/305) | 0.9 | 0.000179 | 0.000616 |
| GO:0072330 | monocarboxylic acid biosynthetic process | 1.64% (5/305) | 3.26 | 0.000203 | 0.000697 |
| GO:0019842 | vitamin binding | 1.64% (5/305) | 3.23 | 0.00022 | 0.000752 |
| GO:0016504 | peptidase activator activity | 0.66% (2/305) | 6.45 | 0.000251 | 0.000853 |
| GO:0045184 | establishment of protein localization | 3.28% (10/305) | 1.97 | 0.000298 | 0.001011 |
| GO:1901575 | organic substance catabolic process | 4.92% (15/305) | 1.51 | 0.000327 | 0.001108 |
| GO:0043650 | dicarboxylic acid biosynthetic process | 0.98% (3/305) | 4.45 | 0.00038 | 0.001281 |
| GO:0016746 | acyltransferase activity | 3.93% (12/305) | 1.7 | 0.000414 | 0.001389 |
| GO:0032012 | regulation of ARF protein signal transduction | 0.66% (2/305) | 5.97 | 0.000491 | 0.001645 |
| GO:0043094 | cellular metabolic compound salvage | 0.98% (3/305) | 4.31 | 0.000501 | 0.001672 |
| GO:0009056 | catabolic process | 4.92% (15/305) | 1.44 | 0.000546 | 0.001815 |
| GO:0032787 | monocarboxylic acid metabolic process | 2.62% (8/305) | 2.14 | 0.000557 | 0.001845 |
| GO:0016407 | acetyltransferase activity | 1.64% (5/305) | 2.94 | 0.000562 | 0.001857 |
| GO:0030036 | actin cytoskeleton organization | 0.98% (3/305) | 4.19 | 0.000639 | 0.002103 |
| GO:0097159 | organic cyclic compound binding | 21.31% (65/305) | 0.57 | 0.000649 | 0.00213 |
| GO:0034032 | purine nucleoside bisphosphate metabolic process | 1.31% (4/305) | 3.35 | 0.0007 | 0.002275 |
| GO:0033865 | nucleoside bisphosphate metabolic process | 1.31% (4/305) | 3.35 | 0.0007 | 0.002275 |
| GO:0033875 | ribonucleoside bisphosphate metabolic process | 1.31% (4/305) | 3.35 | 0.0007 | 0.002275 |
| GO:0006898 | receptor-mediated endocytosis | 0.98% (3/305) | 4.11 | 0.000753 | 0.002439 |
| GO:0071705 | nitrogen compound transport | 3.61% (11/305) | 1.68 | 0.000794 | 0.002563 |
| GO:0030276 | clathrin binding | 0.98% (3/305) | 4.07 | 0.000825 | 0.002654 |
| GO:0004843 | cysteine-type deubiquitinase activity | 1.31% (4/305) | 3.28 | 0.000844 | 0.002706 |
| GO:0046578 | regulation of Ras protein signal transduction | 0.66% (2/305) | 5.47 | 0.000977 | 0.00311 |
| GO:0051056 | regulation of small GTPase mediated signal transduction | 0.66% (2/305) | 5.47 | 0.000977 | 0.00311 |
| GO:0008374 | O-acyltransferase activity | 1.64% (5/305) | 2.75 | 0.000999 | 0.003173 |
| GO:0016776 | phosphotransferase activity, phosphate group as acceptor | 0.98% (3/305) | 3.96 | 0.001027 | 0.003251 |
| GO:0101005 | deubiquitinase activity | 1.31% (4/305) | 3.16 | 0.001144 | 0.003609 |
| GO:0009152 | purine ribonucleotide biosynthetic process | 1.31% (4/305) | 3.14 | 0.001217 | 0.003826 |
| GO:0016579 | protein deubiquitination | 1.31% (4/305) | 3.08 | 0.001421 | 0.004455 |
| GO:0070628 | proteasome binding | 0.66% (2/305) | 5.19 | 0.001432 | 0.004473 |
| GO:0098796 | membrane protein complex | 2.62% (8/305) | 1.91 | 0.001545 | 0.004812 |
| GO:0016866 | intramolecular transferase activity | 1.31% (4/305) | 2.99 | 0.001762 | 0.005469 |
| GO:0090066 | regulation of anatomical structure size | 0.66% (2/305) | 5.03 | 0.001791 | 0.005508 |
| GO:0032535 | regulation of cellular component size | 0.66% (2/305) | 5.03 | 0.001791 | 0.005508 |
| GO:0046483 | heterocycle metabolic process | 9.18% (28/305) | 0.87 | 0.001787 | 0.005532 |
| GO:0019783 | ubiquitin-like protein peptidase activity | 1.31% (4/305) | 2.96 | 0.00192 | 0.005887 |
| GO:0007019 | microtubule depolymerization | 0.66% (2/305) | 4.97 | 0.00194 | 0.005928 |
| GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.97% (6/305) | 2.22 | 0.002057 | 0.006268 |
| GO:0006631 | fatty acid metabolic process | 1.64% (5/305) | 2.49 | 0.00217 | 0.00659 |
| GO:0009112 | nucleobase metabolic process | 0.98% (3/305) | 3.57 | 0.0022 | 0.006662 |
| GO:0043170 | macromolecule metabolic process | 16.39% (50/305) | 0.59 | 0.002262 | 0.006829 |
| GO:0005634 | nucleus | 7.21% (22/305) | 0.96 | 0.002478 | 0.007455 |
| GO:0046907 | intracellular transport | 2.95% (9/305) | 1.67 | 0.002488 | 0.007464 |
| GO:0070646 | protein modification by small protein removal | 1.31% (4/305) | 2.84 | 0.002571 | 0.007688 |
| GO:0016491 | oxidoreductase activity | 5.9% (18/305) | 1.08 | 0.002658 | 0.007925 |
| GO:1901072 | glucosamine-containing compound catabolic process | 0.66% (2/305) | 4.7 | 0.002802 | 0.00828 |
| GO:0006032 | chitin catabolic process | 0.66% (2/305) | 4.7 | 0.002802 | 0.00828 |
| GO:0046348 | amino sugar catabolic process | 0.66% (2/305) | 4.7 | 0.002802 | 0.00828 |
| GO:0006026 | aminoglycan catabolic process | 0.66% (2/305) | 4.69 | 0.002838 | 0.008336 |
| GO:0006030 | chitin metabolic process | 0.66% (2/305) | 4.69 | 0.002838 | 0.008336 |
| GO:0019637 | organophosphate metabolic process | 3.28% (10/305) | 1.53 | 0.002903 | 0.008501 |
| GO:0006164 | purine nucleotide biosynthetic process | 1.31% (4/305) | 2.77 | 0.003029 | 0.008844 |
| GO:0051649 | establishment of localization in cell | 2.95% (9/305) | 1.62 | 0.003107 | 0.009046 |
| GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 1.97% (6/305) | 2.09 | 0.003237 | 0.009395 |
| GO:1901071 | glucosamine-containing compound metabolic process | 0.66% (2/305) | 4.55 | 0.003407 | 0.009859 |
| GO:0048270 | methionine adenosyltransferase regulator activity | 0.33% (1/305) | 8.14 | 0.003547 | 0.010205 |
| GO:0048269 | methionine adenosyltransferase complex | 0.33% (1/305) | 8.14 | 0.003547 | 0.010205 |
| GO:0016868 | intramolecular phosphotransferase activity | 0.66% (2/305) | 4.51 | 0.003607 | 0.010347 |
| GO:0009260 | ribonucleotide biosynthetic process | 1.31% (4/305) | 2.67 | 0.003883 | 0.011107 |
| GO:0010008 | endosome membrane | 0.98% (3/305) | 3.26 | 0.004026 | 0.011482 |
| GO:0046390 | ribose phosphate biosynthetic process | 1.31% (4/305) | 2.62 | 0.00439 | 0.012483 |
| GO:0071702 | organic substance transport | 3.61% (11/305) | 1.35 | 0.004528 | 0.012838 |
| GO:1901999 | homogentisate metabolic process | 0.33% (1/305) | 7.77 | 0.004559 | 0.012851 |
| GO:1902000 | homogentisate catabolic process | 0.33% (1/305) | 7.77 | 0.004559 | 0.012851 |
| GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 0.33% (1/305) | 7.62 | 0.005064 | 0.014073 |
| GO:0036498 | IRE1-mediated unfolded protein response | 0.33% (1/305) | 7.62 | 0.005064 | 0.014073 |
| GO:0019336 | phenol-containing compound catabolic process | 0.33% (1/305) | 7.62 | 0.005064 | 0.014073 |
| GO:1990604 | IRE1-TRAF2-ASK1 complex | 0.33% (1/305) | 7.62 | 0.005064 | 0.014073 |
| GO:0004334 | fumarylacetoacetase activity | 0.33% (1/305) | 7.62 | 0.005064 | 0.014073 |
| GO:0006810 | transport | 6.89% (21/305) | 0.89 | 0.005406 | 0.014981 |
| GO:0097190 | apoptotic signaling pathway | 0.33% (1/305) | 7.48 | 0.005569 | 0.015346 |
| GO:0097193 | intrinsic apoptotic signaling pathway | 0.33% (1/305) | 7.48 | 0.005569 | 0.015346 |
| GO:0032502 | developmental process | 1.64% (5/305) | 2.14 | 0.00602 | 0.016543 |
| GO:0009150 | purine ribonucleotide metabolic process | 1.64% (5/305) | 2.12 | 0.006416 | 0.017532 |
| GO:0097435 | supramolecular fiber organization | 1.31% (4/305) | 2.46 | 0.006401 | 0.017539 |
| GO:0006886 | intracellular protein transport | 1.97% (6/305) | 1.87 | 0.00651 | 0.017739 |
| GO:1902531 | regulation of intracellular signal transduction | 0.66% (2/305) | 4.04 | 0.0068 | 0.018479 |
| GO:0005881 | cytoplasmic microtubule | 0.66% (2/305) | 4.03 | 0.006855 | 0.018576 |
| GO:0030029 | actin filament-based process | 0.98% (3/305) | 2.97 | 0.006984 | 0.018874 |
| GO:0030659 | cytoplasmic vesicle membrane | 0.98% (3/305) | 2.96 | 0.007035 | 0.018907 |
| GO:0012506 | vesicle membrane | 0.98% (3/305) | 2.96 | 0.007035 | 0.018907 |
| GO:0016831 | carboxy-lyase activity | 0.98% (3/305) | 2.93 | 0.007578 | 0.020312 |
| GO:0004568 | chitinase activity | 0.66% (2/305) | 3.94 | 0.007756 | 0.020732 |
| GO:0140030 | modification-dependent protein binding | 0.66% (2/305) | 3.92 | 0.007989 | 0.021297 |
| GO:1990234 | transferase complex | 2.62% (8/305) | 1.5 | 0.008278 | 0.022007 |
| GO:0051261 | protein depolymerization | 0.66% (2/305) | 3.88 | 0.008405 | 0.022283 |
| GO:0051234 | establishment of localization | 6.89% (21/305) | 0.83 | 0.008745 | 0.023124 |
| GO:0006040 | amino sugar metabolic process | 0.66% (2/305) | 3.81 | 0.009139 | 0.0241 |
| GO:2000105 | positive regulation of DNA-templated DNA replication | 0.33% (1/305) | 6.7 | 0.0096 | 0.024913 |
| GO:0034719 | SMN-Sm protein complex | 0.33% (1/305) | 6.7 | 0.0096 | 0.024913 |
| GO:0045793 | positive regulation of cell size | 0.33% (1/305) | 6.7 | 0.0096 | 0.024913 |
| GO:0032877 | positive regulation of DNA endoreduplication | 0.33% (1/305) | 6.7 | 0.0096 | 0.024913 |
| GO:0071010 | prespliceosome | 0.66% (2/305) | 3.78 | 0.009517 | 0.024962 |
| GO:0071004 | U2-type prespliceosome | 0.66% (2/305) | 3.78 | 0.009517 | 0.024962 |
| GO:0032940 | secretion by cell | 0.98% (3/305) | 2.78 | 0.009934 | 0.025713 |
| GO:0016998 | cell wall macromolecule catabolic process | 0.66% (2/305) | 3.7 | 0.010623 | 0.027282 |
| GO:0043186 | P granule | 0.33% (1/305) | 6.55 | 0.010605 | 0.027305 |
| GO:0010011 | auxin binding | 0.33% (1/305) | 6.55 | 0.010605 | 0.027305 |
| GO:0046658 | obsolete anchored component of plasma membrane | 0.98% (3/305) | 2.73 | 0.010923 | 0.027978 |
| GO:0046903 | secretion | 0.98% (3/305) | 2.73 | 0.010989 | 0.028074 |
| GO:0017168 | 5-oxoprolinase (ATP-hydrolyzing) activity | 0.33% (1/305) | 6.48 | 0.011107 | 0.028301 |
| GO:0009259 | ribonucleotide metabolic process | 1.64% (5/305) | 1.92 | 0.011298 | 0.028713 |
| GO:1901293 | nucleoside phosphate biosynthetic process | 1.31% (4/305) | 2.22 | 0.011473 | 0.029007 |
| GO:0009165 | nucleotide biosynthetic process | 1.31% (4/305) | 2.22 | 0.011473 | 0.029007 |
| GO:0008234 | cysteine-type peptidase activity | 1.31% (4/305) | 2.21 | 0.011631 | 0.029258 |
| GO:0032875 | regulation of DNA endoreduplication | 0.33% (1/305) | 6.42 | 0.011609 | 0.029276 |
| GO:0044036 | cell wall macromolecule metabolic process | 0.98% (3/305) | 2.69 | 0.011693 | 0.029336 |
| GO:0051013 | microtubule severing | 0.33% (1/305) | 6.36 | 0.01211 | 0.030307 |
| GO:0000822 | inositol hexakisphosphate binding | 0.33% (1/305) | 6.3 | 0.012612 | 0.031482 |
| GO:1902494 | catalytic complex | 3.61% (11/305) | 1.14 | 0.012967 | 0.032285 |
| GO:0052691 | UDP-arabinopyranose mutase activity | 0.33% (1/305) | 6.24 | 0.013113 | 0.032485 |
| GO:0033356 | UDP-L-arabinose metabolic process | 0.33% (1/305) | 6.24 | 0.013113 | 0.032485 |
| GO:0019693 | ribose phosphate metabolic process | 1.64% (5/305) | 1.86 | 0.013267 | 0.032783 |
| GO:0004614 | phosphoglucomutase activity | 0.33% (1/305) | 6.19 | 0.013614 | 0.033556 |
| GO:0030117 | membrane coat | 0.98% (3/305) | 2.6 | 0.013957 | 0.034314 |
| GO:0004106 | chorismate mutase activity | 0.33% (1/305) | 6.14 | 0.014115 | 0.03453 |
| GO:0044248 | cellular catabolic process | 2.62% (8/305) | 1.36 | 0.014085 | 0.034544 |
| GO:0061134 | peptidase regulator activity | 0.66% (2/305) | 3.45 | 0.014723 | 0.035929 |
| GO:0016514 | SWI/SNF complex | 0.33% (1/305) | 6.04 | 0.015115 | 0.036794 |
| GO:0140352 | export from cell | 0.98% (3/305) | 2.55 | 0.015195 | 0.036897 |
| GO:0009249 | protein lipoylation | 0.33% (1/305) | 5.9 | 0.016614 | 0.040045 |
| GO:0005960 | glycine cleavage complex | 0.33% (1/305) | 5.9 | 0.016614 | 0.040045 |
| GO:0019464 | glycine decarboxylation via glycine cleavage system | 0.33% (1/305) | 5.9 | 0.016614 | 0.040045 |
| GO:0005085 | guanyl-nucleotide exchange factor activity | 0.66% (2/305) | 3.35 | 0.016866 | 0.040554 |
| GO:0034654 | nucleobase-containing compound biosynthetic process | 2.3% (7/305) | 1.42 | 0.017054 | 0.040904 |
| GO:0048193 | Golgi vesicle transport | 1.31% (4/305) | 2.04 | 0.017275 | 0.041333 |
| GO:0140513 | nuclear protein-containing complex | 3.28% (10/305) | 1.14 | 0.017416 | 0.041569 |
| GO:0030132 | clathrin coat of coated pit | 0.33% (1/305) | 5.81 | 0.017612 | 0.041633 |
| GO:0051781 | positive regulation of cell division | 0.33% (1/305) | 5.81 | 0.017612 | 0.041633 |
| GO:0006546 | glycine catabolic process | 0.33% (1/305) | 5.81 | 0.017612 | 0.041633 |
| GO:0030130 | clathrin coat of trans-Golgi network vesicle | 0.33% (1/305) | 5.81 | 0.017612 | 0.041633 |
| GO:0010005 | cortical microtubule, transverse to long axis | 0.33% (1/305) | 5.77 | 0.018111 | 0.042708 |
| GO:0098797 | plasma membrane protein complex | 0.66% (2/305) | 3.29 | 0.01828 | 0.043003 |
| GO:0010498 | proteasomal protein catabolic process | 1.31% (4/305) | 2.01 | 0.01838 | 0.043136 |
| GO:0061863 | microtubule plus end polymerase | 0.33% (1/305) | 5.73 | 0.018609 | 0.04326 |
| GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 0.33% (1/305) | 5.73 | 0.018609 | 0.04326 |
| GO:0030952 | establishment or maintenance of cytoskeleton polarity | 0.33% (1/305) | 5.73 | 0.018609 | 0.04326 |
| GO:0006139 | nucleobase-containing compound metabolic process | 7.54% (23/305) | 0.68 | 0.018501 | 0.043315 |
| GO:0005464 | UDP-xylose transmembrane transporter activity | 0.33% (1/305) | 5.7 | 0.019107 | 0.044208 |
| GO:0046785 | microtubule polymerization | 0.33% (1/305) | 5.7 | 0.019107 | 0.044208 |
| GO:0016301 | kinase activity | 6.23% (19/305) | 0.76 | 0.019328 | 0.044613 |
| GO:0005622 | intracellular anatomical structure | 0.66% (2/305) | 3.24 | 0.019393 | 0.044659 |
| GO:0034515 | proteasome storage granule | 0.33% (1/305) | 5.66 | 0.019605 | 0.045041 |
| GO:0003855 | 3-dehydroquinate dehydratase activity | 0.33% (1/305) | 5.59 | 0.0206 | 0.047217 |
| GO:0043687 | post-translational protein modification | 2.62% (8/305) | 1.26 | 0.020717 | 0.047373 |
| GO:0070647 | protein modification by small protein conjugation or removal | 2.3% (7/305) | 1.36 | 0.020801 | 0.047455 |
| GO:0008361 | regulation of cell size | 0.33% (1/305) | 5.55 | 0.021097 | 0.04802 |
| GO:0099122 | RNA polymerase II C-terminal domain binding | 0.33% (1/305) | 5.52 | 0.021594 | 0.048811 |
| GO:0050815 | phosphoserine residue binding | 0.33% (1/305) | 5.52 | 0.021594 | 0.048811 |
| GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding | 0.33% (1/305) | 5.52 | 0.021594 | 0.048811 |
| GO:0009057 | macromolecule catabolic process | 2.3% (7/305) | 1.34 | 0.022104 | 0.049507 |
| GO:0051219 | phosphoprotein binding | 0.33% (1/305) | 5.48 | 0.022091 | 0.049591 |
| GO:0045309 | protein phosphorylated amino acid binding | 0.33% (1/305) | 5.48 | 0.022091 | 0.049591 |
| GO:0005515 | protein binding | 10.82% (33/305) | 0.53 | 0.022026 | 0.049672 |
